University Hospital, Rouen
Nature of potential dysbiosis, interrelation of the different microbiomes of the respiratory tract, and potential role of the immune system in the pathogenesis of severe asthma in infants, and its evolution under treatment. Exploring and understanding these data is to improve patient care and discover new therapeutic targets. The aim is to open up prospects for therapeutic studies, such as the use of azithromycin as an immunomodulator in infant asthma, the results of which are discordant.
Asthma in Children
Asthma
Blood sample
Expectoration
Nasopharyngeal swab
NA
| Study Type : | INTERVENTIONAL |
| Estimated Enrollment : | 100 participants |
| Masking : | NONE |
| Primary Purpose : | PREVENTION |
| Official Title : | Dynamics of upper and lower respiratory microbiomes associated with severe asthma in infants |
| Actual Study Start Date : | 2023-09-26 |
| Estimated Primary Completion Date : | 2026-09-26 |
| Estimated Study Completion Date : | 2026-09-26 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | to 24 Months |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Rouen University Hospital
Rouen, France,